Profilo
Shoba Murali is the founder.
She founded The UCAN Co. in 2008 and currently holds the title of President & Director.
Ms. Murali also served as Chairman at GlyGenix Therapeutics, Inc. in a former position.
Posizioni attive di Shoba Murali
| Società | Posizione | Inizio |
|---|---|---|
The UCAN Co.
 The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Fondatore | 17/01/2008 |
Precedenti posizioni note di Shoba Murali
| Società | Posizione | Fine |
|---|---|---|
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
The UCAN Co.
The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Retail Trade |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
- Borsa valori
- Insiders
- Shoba Murali
